Faculty profile
Elizabeth Potter
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $539,325
Developing and implementing a core outcome set for adolescents and adults with phenylketonuria
CIHR · 2026 · Nominated PI
- $100,000
Developing and implementing a core outcome set for adolescents and adults with phenylketonuria
CIHR · 2025 · Nominated PI
Novel gene therapy platform for monogenetic lung diseases
CIHR · 2023 · Co-investigator
Developing and implementing a core outcome set for adolescents and adults with phenylketonuria
Principal investigators: Potter, Elizabeth K; Mitchell, John J; Nimmo, Graeme; Pender, Amy; Smith, Maureen M
Keywords: Adolescents; Adults; Clinical Research; Core Outcome Set; Outcomes; Phenylketonuria; Rare Disease; Transition To Adult Care
Developing and implementing a core outcome set for adolescents and adults with phenylketonuria
Principal investigators: Potter, Elizabeth K; Mitchell, John J; Nimmo, Graeme; Pender, Amy; Smith, Maureen M
Keywords: Adolescents; Adults; Clinical Research; Core Outcome Set; Outcomes; Phenylketonuria; Rare Disease; Transition To Adult Care
Novel gene therapy platform for monogenetic lung diseases
Principal investigators: Thebaud, Bernard; Gélinas, Jean-François; Wootton, Sarah
Keywords: Gene Therapy; Respiratory Disease; Surfactant B Deficiency; Viral Vector
An innovative registry-based trials platform to improve clinical care, outcomes, and health policy for children with treatable rare diseases
Principal investigators: Potter, Elizabeth K; McCabe, Christopher; Smith, Maureen M; Binik, Ariella; Chakraborty, Pranesh K; Inbar-Feigenberg, Michal; Mitchell, John J; Offringa, Martin; Oskoui, Maryam; Stockler, Sylvia
Keywords: Comparative Effectiveness; Core Outcomes; Genetic Disease; Innovative Clinical Trial; Orphan Therapy; Patient Partnership; Patient-Oriented Outcomes; Pediatrics; Rare Disease; Registry-Based Randomized Trial
Toward optimal use of ultrasound in prenatal screening for congenital anomalies
Principal investigators: Bellai-Dussault, Kara
Keywords: Clinical Utility; Clinical Validity; Congenital Anomalies; Genetics; Prenatal Screening
Improving the health of infants and children through research that links large health administrative databases with clinical, screening, and laboratory data
Principal investigators: Hawken, Steven; McNally, James D
Keywords: Biostatistics; Clinical Epidemiology; Metabolomics; Newborn Screening; Pregnancy And Birth; Preterm Birth; Respiratory Syncitial Virus; Risk Modelling
Catalyzing registry-based randomized comparative effectiveness trials for inherited metabolic diseases in children: establishing a core outcome set and data collection tools
Principal investigators: Potter, Elizabeth K; Clifford, Tammy J; Pallone, Nicole; Stockler, Sylvia
Keywords: Inherited Metabolic Disease; Pediatrics; Pragmatic Trial; Rare Disease; Registry; Registry-Based Randomized Trial
Engaging patients with rare diseases in research to improve their care
Principal investigators: Boycott, Kym M; McGowan-Jordan, Jean; Graham, Gail E
Keywords: Genetics; Patient Engagement; Quality Improvement; Rare Disease; Research Priorities
Evaluation of Clinical Utility and Cost-effectiveness of Genome-Wide Sequencing in the Canadian Rare Genetic Disease Clinic
Principal investigators: Hartley, Taila S
Keywords: Clinical Utility; Cost-Effectiveness; Genomics; Health Systems; Next Generation Sequencing; Personalized Medicine; Rare Disease
Evidence and values: what role in health policy to divest from screening?
Principal investigators: Nicholls, Stuart G; Clifford, Tammy J; Little, Julian
Keywords: Clinical Practice Guideline; De-Implementation; Ethics; Knowledge Translation; Policy; Population Health; Practice; Screening; Values
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.